US 2015/0147344 A1Published application

BTLA Antibodies and Uses Thereof

AssigneesUniversite D'Aix-Marseille, Inserm (Institut National De La Sante Et De La Recherche Medicale)

InventorDaniel Olive

Life of this patent

Estimating the term…

Abstract

The invention relates to BTLA antibodies that block BTLA-HVEM interaction and uses thereof.

Claims8

Dependent claims

A BTLA antibody comprising the CDRs of the heavy chain variable region and the light chain variable region of the BTLA antibody which is obtainable from the hybridoma accessible under CNCM deposit number I-4123.

Dependencies are inferred from the claim text.

Facts

Application: 14/550,429Filed 21 Nov 2014
Priority: EP 09305246.217 Mar 2009
Published: 28 May 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

C07K 16/2818
Against the immunoglobulin superfamily: against CD28 or CD152
A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 35/00
Antineoplastic agents

Family

Application13/255,977Division · filed 28 Nov 2011
Application14/550,429Division
US 2012/0064096 A1Published application
US 9,896,507 B2Related patent
US 2015/0147344 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…